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The role of ranitidine in the enhancement of imaging quality
in magnetic resonance cholangiopancreatography*
Papel da ranitidina como meio de aprimorar a qualidade do exame de colangiopancreatografia
por ressonância magnética
Lucas Rios Torres1, Elisa Almeida Sathler Bretas1, Galvani Ascar Sauaia Filho2, Adriano Fleury
de Faria Soares2, Giuseppe D’Ippolito3
Objective: To assess the impact of oral ranitidine on the imaging quality in magnetic resonance cholangiopancreatography
(MRCP). Materials and Methods: Thirty-two patients underwent MRCP with 3D and 2D acquisitions, and three strategies
for suppression of the gastrointestinal fluid signal: a) only at fasting; b) 12 hours after ingestion of 300 mg ranitidine;
c) after oral administration of gadolinium solution. Three observers reviewed the images with a focus on the degree of
visualization of the biliopancreatic tree. The interobserver agreement was evaluated with the kappa test. The difference
between techniques and acquisition modalities were evaluated by means of average grading scores. Results: The three
strategies for suppression of the gastrointestinal fluid signal presented high reproducibility. The results with suppression
of the gastrointestinal fluid signal with ranitidine where similar to those obtained with fasting, and both were worse than
those obtained with gadolinium solution. The 3D acquisitions surpassed 2D only in terms of visibility of the cystic duct
and gallbladder, and were inferior or equivalent in the other biliopancreatic ductal segments. Conclusion: The use of
ranitidine does not seem justified in the evaluation of the biliopancreatic tree at MRCP, since 2D MRCP with fasting
allows the visualization of ductal structures with high quality and reproducibility in the majority of cases.
Keywords: Ranitidine; Diagnostic use; Magnetic resonance cholangiopancreatography; Contrast media; Bile ducts;
Pancreatic ducts.
Objetivo: Avaliar o impacto da ranitidina por via oral na qualidade do exame de colangiopancreatografia por ressonân-
cia magnética (CPRM). Materiais e Métodos: Trinta e dois pacientes realizaram CPRM com aquisições 3D e 2D, com
três estratégias de supressão do sinal líquido gastrintestinal: a) apenas em jejum; b) 12 horas após ingerir 300 mg de
ranitidina; c) após a ingestão de solução de gadolínio. Três observadores avaliaram os estudos, atentos para o grau de
visualização da árvore biliopancreática. Foi medida a concordância interobservador com o teste kappa. A diferença
entre técnicas e formas de aquisição foi avaliada pela média da soma dos escores de graduação. Resultados: As três
estratégias de supressão do sinal líquido gastrintestinal apresentaram elevada reprodutibilidade. A supressão do sinal
líquido gastrintestinal com a ranitidina foi semelhante ao jejum e ambas foram piores do que a solução de gadolínio.
As aquisições 3D superaram a 2D apenas na visualização do ducto cístico e da vesícula biliar, sendo inferior ou equi-
valente nos demais segmentos ductais biliopancreáticos. Conclusão: O uso da ranitidina não parece justificado para
aprimorar a avaliação da árvore biliopancreática em exames de CPRM. A CPRM 2D apenas em jejum permite a visuali-
zação ductal com elevada qualidade e reprodutibilidade na maioria dos casos.
Unitermos: Ranitidina; Uso diagnóstico; Colangiopancreatografia por ressonância magnética; Meios de contraste; Ductos
biliares; Ductos pancreáticos.
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for the formation of the image(1). As a gen-
eral rule, MRCP studies are performed both
under breath-hold (2D MRCP) and with
respiratory triggering (3D MRCP). This
strategy seeks to combine the inherent ad-
vantages from each of the two modalities,
such as the short acquisition time of the 2D
sequence and the higher spatial resolution
obtained with the 3D techniques(2,3).
On account of its projectional nature,
the signal from the gastrointestinal fluid
INTRODUCTION
The term magnetic resonance cholan-
giopancreatography (MRCP) can be ex-
tended to a number of imaging acquisition
techniques whose main characteristic is ex-
ploring a long T2 relaxation time of the flu-
ids contained within the biliopancreatic tree
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can be superimposed over the biliopan-
creatic tree, limiting the diagnostic quality
of the method(4). The signal from the gas-
trointestinal fluid may be abolished or re-
duced by three strategies as follows: pro-
longed fasting; intake of a negative oral
contrast agent(5); or by means of reduction
of gastric secretion with pharmaceuticals(6).
Negative contrast agents are paramag-
netic solutions which promote reduction in
signal intensity of the gastrointestinal fluid
for shortening the T2 relaxation time at the
magnetic resonance imaging (MRI).
Among this group of substances one may
find from industrialized products contain-
ing iron(7) to juices where the fruit mineral
concentrations (for example: manganese in
pineapple) is strong enough to reduce the
T2 relaxation time(8,9). Paramagnetic oral
contrast agents are expensive, not palatable
and may cause side effects(7). As regards
juices, differences in the mineral concen-
tration required for suppressing the gas-
trointestinal liquid signal may occur in the
household preparation of the solutions, as
well as in the industrialized solutions, mak-
ing them ineffective.
On the other hand, pharmaceuticals
such as ranitidine are inexpensive, widely
available, can be easily administered and
with a low incidence of side effects(10), and
do not require a medical prescription to be
bought. At least one study has demon-
strated ranitidine contribution in the evalu-
ation of biliary tract with MRI, for reduc-
ing the gastroduodenal fluid signal and
minimizing its interference on the visual-
ization of the biliopancreatic tree(6). For
that reason, the authors of the present study
have decided to confirm the value of oral
ranitidine in the evaluation of the
biliopancreatic tree in MRCP studies.
MATERIALS AND METHODS
The present study was approved by the
Committee for Ethics in Research of the
institution. A term of free and informed
consent was signed by all the individuals
participating in the study.
A prospective, cross-sectional, observa-
tional and self-paired study was under-
taken. The proposal for undergoing MRCP
was opened to healthy and cooperative in-
dividuals aged above 18, who agreed in
participating in the study. Any relative or
absolute contraindication for MRI (for ex-
ample: cardiac pacemaker, brain aneurysm
clips, cochlear implants, claustrophobia),
previous history of allergy to the drug and
use of synergistic drugs (for example: di-
azepam, ketoconazole, clarithromycin,
phenytoin and warfarin) were considered
as exclusion criteria.
The MRCP scans were performed in 32
volunteers, 12 women and 20 men, with
ages between 27 and 63 years, mean age of
32 years. No exclusion was observed.
Patients preparation
The following steps were undertaken:
First step – MRCP with no medication
and after at least four-hour fasting, acquir-
ing images with 2D and 3D techniques.
Second step – On the same day, MRCP
after oral intake of negative contrast me-
dium, acquiring images with 2D and 3D
techniques. The negative contrast medium
was a solution with 5 ml of gadolinium in
75 ml of water, as described in the litera-
ture(5).
Third step – MRCP under at least four-
hour fasting and 12 hours after ingestion of
300 mg of ranitidine (peak of action) ac-
quiring the images with 3D and 2D tech-
niques. The mean time span between the
first two steps and the third step was 30
days, ranging from 21 to 35 days.
Equipment and technique
All the scans were performed in a MRI
equipment operating with a 1.5 T magnetic
field, model Gyroscan Intera® (Release 13)
(Philips Medical Systems; Best, The Neth-
erlands) equipped with a synergy sense
body coil for signal emission and reception.
The parameters for MRCP images ac-
quisition were identical in the three steps,
namely:
– 3D MRCP: repetition time (TR) =
1433; echo time (TE) = 650; NEX = 1;
matrix = 256 × 205; slice thickness = 1.6
mm; gap = 0.8 mm with 80% overlap; turbo
factor (TF) = 144; flip angle of 90 degrees;
field of view (FOV) = 512 × 512; echo
spacing = 9.9 ms; bandwidth = 723 Hz; and
acquisitions during the final expiratory
phase utilizing respiratory triggering (RT).
The mean acquisition time was five min-
utes.
– 2D MRCP: TR = 8000; TE = 800;
NEX = 1; matrix = 228 × 182; slice thick-
ness = 4.0 cm; TF = 182; flip angle = 90
degrees; FOV = 380 × 380; bandwidth of
320 Hz; 6 radial coronal acquisitions cen-
tered on the bile duct, at an angle of 15
degrees and obtained with breath-hold. The
time spent for each acquisition (slab of 4.0
cm) was 2 seconds, and for the entire se-
quence, less than 30 seconds.
Images evaluation
The images were independently and ran-
domly evaluated by three different observ-
ers (observer 1, with 10-year experience in
general radiology; observer 2, with 4-year
experience in general radiology and 2-year
experience in abdominal radiology; ob-
server 3, with 4-year experience in general
radiology). There was no consensual analy-
sis in cases of interobserver disagreement.
The images were filed in DICOM for-
mat and were displayed on high-resolution
displays utilizing the Osirix® platform. In
order to avoid learning bias, the identifica-
tion of patients and fluid signal suppression
technique were replaced by codes.
The 3D MRCP images were initially
evaluated, also utilizing the millimetric sec-
tions of the source images and multiplanar
reconstructions with the MIP technique.
The observers were totally free to perform
reconstructions in other planes, change the
imaging windows according to their pref-
erences as well as changing the reconstruc-
tion thickness with the MIP technique.
Each evaluation session was held at an in-
terval of at least two weeks.
The 2D acquisition images were later
evaluated. Similarly to the previous evalu-
ation sessions, the observers were free to
change the images parameters as they
found convenient.
Evaluation parameters
The following ductal segments were
evaluated:
– Main right hepatic ducts branch: de-
fined as the segment interposed between
the ductal hilar confluence and its first-or-
der branching.
– Main left hepatic ducts branch: de-
fined as the segment interposed between
the ductal hilar confluence and its first-or-
der branching.
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– Common hepatic duct: Segment inter-
posed between the hilar confluence of the
main left and right branches and the cystic
duct insertion.
– Bile duct: defined as the ductal seg-
ment located below the cystic duct. The bile
duct was arbitrarily defined as pancreatic
(2 cm above its exit into the duodenum) and
suprapancreatic (the remaining segment).
– Cystic duct: ductal structure extend-
ing from the gallbladder neck to the bile
duct.
– Head of the pancreatic duct: up to 5
cm from the biliopancreatic junction(11).
– Body of the pancreatic duct: between
5 and 7 cm of the biliopancreatic junc-
tion(11).
– Tail of the pancreatic duct: 7 cm be-
yond the biliopancreatic junction(11).
– Gallbladder.
Qualitative images evaluation
The degree of gastrointestinal fluid sig-
nal suppression was evaluated according to
the following scale:
1 – The hyperintense signal present in
the stomach and in the duodenum impairs
the analysis of the structure.
2 – The hyperintense signal present in
the stomach and in the duodenum partially
impairs the analysis of the structure.
3 – The hyperintense signal present in
the stomach and in the duodenum does not
impair the analysis of the structure.
4 – There is no signal present inside the
stomach and the duodenum.
The ductal visualization was evaluated
according to the following scale:
0 – The duct is not visualized.
1 – The duct is partially visualized and
defined.
2 – The duct is clearly visualized and de-
fined.
Statistical analysis
The sum of the scores assigned by the
three observers for the visualization vari-
able (ranging between 0 and 2), so as the
score value was a minimum of 0 and a
maximum of 6. The same was done to
evaluate the degree of gastrointestinal fluid
signal suppression (ranging between 1 and
4), where the sum of scores could range
from 3 to 12. Such a method was applied
for both image acquisition techniques (2D
and 3D) and for the three gastroduodenal
fluid signal suppression techniques (fast-
ing, ranitidine and oral contrast).
The two-way analysis of variance
(ANOVA) was utilized to verify significant
differences between acquisition techniques
(2D and 3D). In the case of statistical sig-
nificance, the Tukey multiple comparison
test was utilized.
The interobserver agreement was evalu-
ated by means of the kappa (κ) test. Value
of κ lower than 0.4 indicate low agreement;
values between 0.41 and 0.60 indicate
moderate agreement; between 0.61 and
0.80 indicate substantial agreement; above
0.81 indicate excellent agreement(12).
The established significance level was
p > 0.05.
RESULTS
Interobserver agreement
The interobserver agreement in relation
to the degree of gastrointestinal fluid sig-
nal suppression was considered as being
substantial, ranging between κ = 0.63 and
κ = 0,73. For the qualitative assessment of
the visualization of biliopancreatic duct
segments, the interobserver agreement was
moderate, ranging between κ = 0.41 and κ
= 0.48. The images were considered as
having diagnostic effectiveness when the
biliopancreatic tree was partially or com-
pletely visualized (visualization score 1 and
2). On the other hand, images without di-
agnostic effectiveness were those where a
determined biliopancreatic duct segment
was not identified (score 0). As the images
were grouped as “with diagnostic effective-
ness” (visualization scores 1 and 2) and
“without diagnostic effectiveness” (visual-
ization category 0), the agreement about
visualization of the biliopancreatic tree
became substantial (Table 1). No statisti-
cally significant difference was observed in
relation to the number of images with di-
agnostic effectiveness among the three
techniques (fasting, ranitidine and oral
negative contrast) (Table 2).
Gastrointestinal fluid signal suppression
The utilization of oral contrast agent
was the strategy by which the highest sup-
pression scores were achieved (Figures 1
and 2), and the difference with other gas-
trointestinal fluid signal suppression strat-
egies (fasting and ranitidine) were statisti-
cally significant for any of the two acqui-
sition techniques (2D × 3D) (p = 0.02). No
statistically significant difference was ob-
served between the scores obtained with
ranitidine and fasting in both image ac-
quisition techniques. The effect of the
negative contrast on all segments is pre-
sented on Figure 3, where the scores for the
three strategies for gastrointestinal fluid
signal suppression with both acquisition
techniques are represented.
Ten segments of the biliopancreatic tree
were evaluated. All the 32 patients were
evaluated six times (three times on 3D ac-
quisitions and three times on 2D acquisi-
tions). Thus, each observer performed
1,920 image analyses. The scores 1 and 2
(when the gastrointestinal fluid signal par-
tially or totally impairs the biliopancreatic
tree evaluation) occurred in only 3.2% of
all evaluations, being most commonly ob-
served in the analysis of the cystic duct on
2D acquisitions by the less experienced
observers (Figure 4).
Degree of ductal visualization
The quality of ductal visualization kept
a closer relationship with the acquisition
technique (2D × 3D) than with the gas-
Table 1 Interobserver agreement between diag-
nostic and non-diagnostic images.
Observer
1 × 2
1 × 3
2 × 3
Kappa
0.64
0.69
0.63
Grading
Substantial
Substantial
Substantial
Table 2 Percentage of images with diagnostic capability among the different gastrointestinal fluid sig-
nal suppression strategies.
Observer
1
2
3
Ranitidine
84.84%
87.66%
86.41%
Fasting
82.24%
91.21%
88.43%
Oral contrast
87.74%
90.81%
89.03%
p
Non-significant
Non-significant
Non-significant
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Figure 2. Comparison between strategies for gastrointestinal fluid signal reduction at 3D MIP reconstructions with ranitidine (A), fasting (B) and with gado-
linium solution (C). The gastrointestinal fluid signal is similar with the ranitidine and fasting strategies. Arrow on C identifies the cystic duct. E, stomach; D,
duodenum.
trointestinal fluid signal suppression strat-
egy (Table 3).
For the right, left and common hepatic
ducts, and the suprapancreatic segment of
the bile duct, there was neither statistically
significant difference between the acquisi-
tion techniques (2D × 3D) nor between the
gastrointestinal fluid signal suppression
strategies.
For the cystic duct and the gallbladder,
the acquisitions with the 3D technique
achieved higher visualization scores.
For the pancreatic segment of the bile
duct, and for the entire extent of the pancre-
atic duct, the 2D acquisition surpassed the
3D acquisition technique, and such differ-
ence was statistically significant (Figure 5).
The evaluation of the gallbladder and
cystic duct was significantly superior with
ingestion of the gadolinium solution. In the
remaining segments of the biliopancreatic
tree the ductal visualization was similar
among the three gastrointestinal fluid sig-
nal suppression techniques (Table 3).
For the three observers, in the majority
of images, the 2D and 3D acquisition tech-
niques presented similar performances in
the visualization of the biliopancreatic tree
(Table 4).
In all studied ductal segments, the gas-
trointestinal fluid signal suppression strat-
egy with ingestion of ranitidine did not
result in a better evaluation of the biliopan-
creatic tree as compared with the other two
strategies, and there was no statistically
significant difference in comparison with
Figure 1. 3D MIP reconstructions with ranitidine (A), fasting (B) and with gadolinium solution (C). Decreased signal of the stomach (E) and of the duodenum
(D) with the utilization of negative oral contrast agent. The cystic duct (arrow on C) was better characterized with oral gadolinium solution.
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Figure 3. 2D sequence after fasting where, in spite of angled acquisitions, the cystic duct superposition persisted. Detail of small vesicular polyp on image D
(arrow). E, stomach; d, duodenum.
Table 3 Values for statistical significance of gastrointestinal fluid signal suppression strategies and for
the image acquisition techniques.
p value
2D × 3D
Gd × R × F
RHD
0.054
0.13
LHD
0.71
0.41
CHD
0.15
0.41
CD
0.001
0.68
GB
0.001
0.04
SBD
0.15
0.99
PD
0.01
0.53
HPD
0.02
0.09
BPD
0.006
0.25
RHD, right hepatic duct; LHD, left hepatic duct, CHD, common hepatic duct; CD, cystic duct; GB; gall bladder;
SBD, suprapancreatic bile duct; PD, pancreatic duct; HPD, head of the pancreatic duct; BPD, body of the
pancreatic duct; TPD, tail of the pancreatic duct; Gd × R × F, gadolinium × ranitidine × fasting. Note: Bold
numbers demonstrate statistical significance.
TPD
0.02
0.01
Figure 4. All segments of the pancreatic duct are identified at the 2D acquisition with gadolinium solution (arrows on A). At the 3D MIP sequence (B) only its
cephalic segment is partially identified (arrow).
the scans performed after fasting only. In
the evaluation of the tail of the pancreatic
duct, a worse definition was observed on
the images obtained after the utilization of
ranitidine (Figure 6), as compared with the
images obtained with other strategies for
gastrointestinal fluid signal suppression
(Table 3).
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DISCUSSION
MRCP is the main non-invasive imag-
ing method utilized in the evaluation of
biliopancreatic disorders. Its accuracy is
similar to that obtained at endoscopic ret-
rograde cholangiopancreatography in the
diagnosis of choledocholithiasis, biliary
obstruction and sclerosing cholangitis(13,14),
without the potential risks involved in such
invasive procedure(15). In order to obtain
such expected results, it is essential to as-
sure a good imaging quality, which is ex-
pressed by the degree of ductal visualiza-
tion(16). The inappropriate characterization
of the biliopancreatic tree ducts may origi-
nate from the presence of motion artifacts
caused by peristaltic and respiratory move-
ments and enteric fluid overlap(17). In the
present study, the authors have tried to
demonstrate the results achieved in terms
of ductal visualization at MRCP when dif-
ferent strategies are adopted, with the pur-
pose of minimizing the superposition of
gastrointestinal fluid over the biliary and
pancreatic trees.
Among such strategies, the adoption of
gadolinium solution in water was the best
form to abolish the signal from the gas-
trointestinal fluid. As regards the pharma-
cological strategy utilizing oral ranitidine,
the results of the present study were not
similar to those reported by a previous
study(5). No significant difference was ob-
served as regards reduction in signal be-
tween scans performed after fasting and
after ingestion of 300 mg ranitidine.
Ranitidine reduces the gastric acid secre-
tion thanks to its action on the H2 receptors,
reducing the hydrogen protons concentra-
tion in the gastric juice(10). On their turn,
gastric juices are utilized in the formation of
the images at the MRI. There are studies
demonstrating a linear relationship between
the signal intensity measured by MRI and
local concentration of hydrogen(18,19). Prob-
ably, there was a difference in the concen-
tration of such ions in the gastric juice as
the patients underwent the scans after fast-
ing and after ranitidine intake. However,
such difference was not expressed in terms
of amount of signal of the gastrointestinal
fluid perceived by the observers. Another
point to be considered is the effect of raniti-
dine on the gastric motility. According some
authors, there is a prokinetic effect, accel-
erating the gastric emptying, while for oth-
ers there is an opposed effect(20–23), which
can influence the results regarding the
amount of fluid inside the gastric cavity.
Such point is still controversial and should
be further investigated in new studies about
gastroduodenal motility. The ranitidine
dose and its intake timing represent other
issues which might have influenced its ef-
fectiveness in obtaining a more expressive
reduction of gastric secretion. However
such variables were compatible with those
utilized in other studies and supported by
their pharmacological action(6,10).
A worsening in the visualization of the
caudal segment of the pancreatic duct was
observed with the utilization of ranitidine
in both acquisition techniques (2D and 3D).
Bowers et al. have also mentioned a non-
significant reduction in the visualization of
the pancreatic duct in their study, but those
authors did not make any further comment
on such a finding(6). The present study au-
thors’ hypothesis is that the basal gastric
Figure 5. 3D MIP reconstructions with the utilization of ranitidine (A); oral gadolinium solution (B); and after fasting (C). Observe the difference in the visual-
ization degree of the pancreatic duct in the same patient (arrows on B and C).
Table 4 Frequency of similar performance (=) or different performance (> or <) in the biliopancreatic
tree evaluations with 2D and 3D acquisition techniques, according to the three observers.
2D = 3D
2D > 3D
3D > 2D
Observer 1
78.9%
11.5%
9.5%
Observer 2
64.1%
15.9%
19.8%
Observer 3
64.2%
20.0%
15.7%
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acid secretion maintains some stimulus
over the exogenous pancreatic bicarbonate
secretion, which would cause fluid to be
present in the pancreatic ductal lumen, and
consequential MRI signal on cholangio-
graphic sequences. On the contrary, the
gastric secretion suppression caused by
ranitidine would limit such an effect.
Fluid superposition impairing the duc-
tal visualization was not a frequent event,
identified in only 3.2% of the scans. Such
finding was more common for the cystic
duct in 2D acquisitions. These scores were
most frequently observed in the analyses
undertaken by the less experienced observ-
ers. As far as one could observe, the present
study is the first to identify the frequency
in which the fluid superposition limits the
ductal visualization, and also the first to
relate it to the observers’ experience degree.
The visualization score was rather re-
lated to the acquisition modality and loca-
tion of the evaluated segment. According
to the present study results, the sequences
obtained with the 3D and RT techniques
improved the degree of visualization of the
cystic duct and of the gallbladder. In the
remaining segments, the visualization
scores obtained with breath-hold sequences
were equivalent or higher than those ob-
tained with 3D sequences. Such aspect was
mostly observed on the pancreatic duct
images. According to some authors, there
is superiority in the visualization of this
segment as its anatomic plane is contained
within the acquisition block, like in the 2D
technique(24). Furthermore, reconstructions
with MIP technique from images obtained
with the 3D technique may exacerbate
motion artifacts(25). Considering such as-
pects and the shorter acquisition time for
imaging with the 2D breath-hold tech-
nique, it is justifiable to initiate the MRCP
scan with this acquisition technique. In
those cases where some ductal segment,
crucial for diagnosis definition, is not ap-
propriately represented with the 2D tech-
nique, the scan may be supplemented with
images acquired with RT and the 3D tech-
nique. In cases where fasting alone was the
strategy utilized for gastrointestinal fluid
signal suppression, the use of negative oral
contrast agent would have been necessary
in three (9%) of the 32 cases for observer
1, in none for observer 2, and in five cases
(15%) for observer 3. Gastrointestinal fluid
signal suppression would be useful particu-
larly in the evaluation of the cystic duct
only in 2D acquisitions.
In summary, the three observers sub-
stantially agreed in relation to the fact that
the signal from the enteric juice is rarely a
factor which affects the biliopancreatic tree
visualization degree as the scan is performed
after fasting. For that reason, the authors
consider, similarly to other authors, that the
utilization of negative contrast agent may
be dispensable in MRCP scans(2). However,
there is no consensus in the literature with
respect to this theme(9). Some authors have
put forward opinions which are based on
their experience, rather than on hard evi-
dences, indicating that the use oral contrast
agent is not necessary(1). On the other hand,
others have demonstrated the usefulness of
such a strategy to improve the visualization
of the biliopancreatic tree(5,17). It is impor-
tant to notice that the latter have not utilized
the radial sequence in the 2D breath-hold
acquisitions, or have not performed the 3D
sequences with RT in the routine evaluation
of the biliopancreatic tree in their studies,
contrarily to what was done in the present
study, and which reduces the undesired su-
perposition of the gastric juice with the
biliopancreatic ducts. That would explain
the discrepancy obtained in the present
study as compared with previous ones, to-
wards considering the use of oral contrast
unnecessary, since the different angles of
radial and volumetric acquisitions avoid
the fluid superposition on the biliopan-
creatic tree mapping.
The present study faced some limita-
tions. The first one is the fact that patient
fasting time was not controlled; only a
minimum fasting time of at least four hours
between the last meal and the scan was
established; some patients may have fasted
for longer than four hours, as it occurs in
the daily practice. The second limitation
was the fact that volunteers’ diet was not
controlled. Some types of food can retard
the gastric emptying, which may eventually
reduce the efficacy of fasting as a strategy
for reducing ductal superposition; how-
ever, limiting the intake of certain foods is
not common in the patient preparation in-
structions for MRCP scans. The third limi-
tation was the fact that no antiperistaltic
drugs were utilized. Sodickson et al. report
the finding of motion artifacts caused by
peristaltic movements under the form of
noise dispersed throughout the image on
3D MRCP acquisitions, leading to poor
definition of ductal contours(26). This may
have compromised image quality in 3D
acquisitions; on the other hand, consider-
ing that some patients are sensitive to sco-
polamine, avoiding the utilization of such
type of drug increases the tolerance to the
procedure. Finally, the new respiratory-trig-
gered techniques by means of diaphrag-
matic motion monitoring (PACE)(27) seem
to be superior to that utilized for the present
study. This may have favored the 2D se-
quences in the present study, i.e., adopting
more updated RT techniques might have
improved the quality of the images ob-
tained in 3D and make them better than
those obtained with the breath-hold tech-
nique. On the other hand, it should be con-
sidered that new techniques for breath-hold
acquisition might equally optimize results
in the biliopancreatic tree evaluation by
MRCP.
In the evaluation of conditions affecting
the pancreatic and biliary tract, MRCP has
been playing an increasing role on account
of its many advantages and complementar-
ity with ultrasonography(28–30). Establishing
a MRCP exam protocol that makes it sim-
pler, faster and more efficient without im-
pairing its diagnostic capability is impor-
tant, and the present study is aimed at con-
tributing in such sense.
Finally, the present study demonstrates
that the utilization of oral ranitidine does
not bring significant benefits to the image
quality in MRCP studies. It is possible to
perform the scan in a simplified way and
with good quality by utilizing the breath-
hold acquisition technique and after fast-
ing. By dispensing with the use of time
consuming acquisition sequences with RT
and gastrointestinal fluid signal reduction
strategies (either pharmacological or in-
volving the use of oral contrast agents), and
utilizing fast breath-hold sequences, one
should save time and resources.
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